Global Information
회사소개 | 문의

아토피성 피부염 : 주요 21개국 시장 예측

EPIOMIC EPIDEMIOLOGY SERIES: ATOPIC DERMATITIS FORECAST IN 21 MAJOR MARKETS 2018-2028

리서치사 Black Swan Analysis
발행일 2018년 07월 상품 코드 345243
페이지 정보 영문 92 Pages
가격
US $ 5,800 ₩ 6,617,200 PDF by E-mail (Single User License)
US $ 8,700 ₩ 9,925,800 PDF by E-mail (Site License)
US $ 10,400 ₩ 11,865,300 PDF by E-mail (Global License)


아토피성 피부염 : 주요 21개국 시장 예측 EPIOMIC EPIDEMIOLOGY SERIES: ATOPIC DERMATITIS FORECAST IN 21 MAJOR MARKETS 2018-2028
발행일: 2018년 07월 페이지 정보 : 영문 92 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

주요 21개국 시장(미국, 캐나다, 프랑스, 독일, 이탈리아, 스페인, 영국, 폴란드, 네덜란드, 러시아, 터키, 남아프리카공화국, 일본, 중국, 한국, 싱가포르, 인도, 호주, 브라질, 멕시코, 아르헨티나)의 아토피성 피부염(ATOPIC DERMATITIS) 현재 환자수(성별, 연령 그룹별)에 대해 조사 분석했으며, 현재 유병률, 질환 개요, 위험인자, 질환의 진단과 예후, 주요 증상과 합병증 등의 정보를 정리하여 전해드립니다.

1. 도표

2. 서론

3. 병인

4. 위험인자와 예방

5. 질환 진단

6. 변이 : 지역/민족별

7. 질환의 예후와 임상 경과

8. 질환에 관련된 주요 합병증/특징

9. 환자수 정량화 방법

10. 아토피성 피부염 최대 환자수

11. 아토피성 피부염 환자의 특징

  • 징후와 증상
  • 기타 특징
  • 아토피성 피부염 환자의 병존질환

12. 약어

13. 기타 서비스 및 솔루션

  • 보고서 및 출판물
  • 온라인 역학 데이터베이스
  • 온라인 약가 데이터베이스

14. 참고 문헌

15. 부록

LSH 18.07.12

영문목차

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Atopic Dermatitis in 21 Major Markets

Atopic Dermatitis, also known as eczema, is a common disorder of the epidermis of the skin causing dryness, itchiness, red rashes, inflammation, sores and blisters. It occurs mostly in early childhood and can develop from exposure to allergens and irritants, such as dust mites, pollen, peanuts and so forth. The prognosis for most patients is improvement in symptoms, and by adulthood it may disappear altogether.

This report provides the current prevalent population for Atopic Dermatitis across 21 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, South Africa, Japan, China, South Korea, Singapore, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of severity, location and IgE levels of Atopic Dermatitis, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Atopic Dermatitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Atopic Dermatitis include:

Asthma

Rhinitis

Allergies (Food- or Inhalant-related)

Rashes

Eczemic lesions

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

Able to quantify patient populations in global Atopic Dermatitis market to target the development of future products, pricing strategies and launch plans.

Gain further insight into the prevalence of the subdivided types of Atopic Dermatitis and identify patient segments with high potential.

Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

Provide a level of understanding on the impact from specific co-morbid conditions on Atopic Dermatitis prevalent population.

Identify sub-populations within Atopic Dermatitis which require treatment.

Gain an understanding of the specific markets that have the largest number of Atopic Dermatitis patients.

CONTENTS

  • LIST OF TABLES AND FIGURES
  • INTRODUCTION
  • CAUSE OF THE DISEASE
  • RISK FACTORS & PREVENTION
  • DIAGNOSIS OF THE DISEASE
  • VARIATION BY GEOGRAPHY/ETHNICITY
  • DISEASE PROGNOSIS & CLINICAL COURSE
  • KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE
  • METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS
  • TOP-LINE PREVALENCE FOR ATOPIC DERMATITIS
  • FEATURES OF ATOPIC DERMATITIS PATIENTS
  • SIGNS AND SYMPTOMS
  • OTHER FEATURES
  • COMORBIDITIES OF ATOPIC DERMATITIS PATIENTS
  • ABBREVIATIONS USED IN THE REPORT
  • OTHER BLACK SWAN SERVICES & SOLUTIONS
  • REPORTS & PUBLICATIONS
  • ONLINE EPIDEMIOLOGY DATABASES
  • ONLINE PHARMACEUTICAL PRICING DATABASE
  • REFERENCES
  • APPENDIX

LIST OF TABLES AND FIGURES

  • Table 1. Prevalence of atopic dermatitis, total (000s)
  • Table 2. Prevalence of atopic dermatitis, males (000s)
  • Table 3. Prevalence of atopic dermatitis, females (000s)
  • Table 4. Patients with atopic dermatitis by average no. of days per year with symptoms, total (000s)
  • Table 5. Patients with atopic dermatitis by disease severity, total (000s)
  • Table 6. Patients with atopic dermatitis by frequency of flare in past 12 months, total (000s)
  • Table 7. Atopic dermatitis patients with excessive dryness/scaling of the skin, total (000s)
  • Table 8. Atopic dermatitis patients with red or inflamed rash, total (000s)
  • Table 9. Atopic dermatitis patients with blisters/bumps, total (000s)
  • Table 10. Atopic dermatitis patients with thickening of the skin, total (000s)
  • Table 11. Atopic dermatitis patients with open or oozing sores, total (000s)
  • Table 12. Atopic dermatitis patients with lesions on arms or hands, total (000s)
  • Table 13. Atopic dermatitis patients with lesions on legs or feet, total (000s)
  • Table 14. Atopic dermatitis patients with lesions on head, face or scalp, total (000s)
  • Table 15. Atopic dermatitis patients with lesions on chest, abdomen or back, total (000s)
  • Table 16. Atopic dermatitis patients with lesions on groin or underarm, total (000s)
  • Table 17. Atopic dermatitis patients with lesions on the skinfold of arms or legs, total (000s)
  • Table 18. Atopic dermatitis patients with lesions on elbows or knees, total (000s)
  • Table 19. Patients with atopic dermatitis by IgE levels (kU/L), total (000s)
  • Table 20. Atopic dermatitis patients with filaggrin mutation, total (000s)
  • Table 21. Patients with atopic dermatitis by disease inheritance status, total (000s)
  • Table 22. Atopic dermatitis patients with asthma, total (000s)
  • Table 23. Atopic dermatitis patients with allergic rhinitis, total (000s)
  • Table 24. Atopic dermatitis patients with contact dermatitis, total (000s)
  • Table 25. Atopic dermatitis patients with psoriasis, total (000s)
  • Table 26. Atopic dermatitis patients with vitiligo, total (000s)
  • Table 27. Atopic dermatitis patients with allergy to egg white, total (000s)
  • Table 28. Atopic dermatitis patients with allergy to cow milk, total (000s)
  • Table 29. Atopic dermatitis patients with allergy to peanuts, total (000s)
  • Table 30. Atopic dermatitis patients with inhalant allergy to house dust mite, total (000s)
  • Table 31. Atopic dermatitis patients with inhalant allergy to cat dander, total (000s)
  • Table 32. Atopic dermatitis patients with inhalant allergy to tree pollen, total (000s)
  • Table 33. Atopic dermatitis patients with inhalant allergy to grass pollen, total (000s)
  • Table 34. Atopic dermatitis patients with inhalant allergy to Alternaria, total (000s)
  • Table 35. Abbreviations and acronyms used in the report
  • Table 36. USA prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 37. USA prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 38. Canada prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 39. Canada prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 40. France prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 41. France prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 42. Germany prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 43. Germany prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 44. Italy prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 45. Italy prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 46. Spain prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 47. Spain prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 48. UK prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 49. UK prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 50. Poland prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 51. Poland prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 52. Netherlands prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 53. Netherlands prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 54. Russia prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 55. Russia prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 56. Turkey prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 57. Turkey prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 58. South Africa prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 59. South Africa prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 60. Japan prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 61. Japan prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 62. China prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 63. China prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 64. South Korea prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 65. South Korea prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 66. Singapore prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 67. Singapore prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 68. India prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 69. India prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 70. Australia prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 71. Australia prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 72. Brazil prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 73. Brazil prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 74. Mexico prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 75. Mexico prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
  • Table 76. Argentina prevalence of atopic dermatitis by 5-yr age cohort, males (000s)
  • Table 77. Argentina prevalence of atopic dermatitis by 5-yr age cohort, females (000s)
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
La Merie Publishing
BCC Research